70
Olofsson B, Korpelainen E, Pepper MS, et al. Vascular endothelial growth factor B
(VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in
endothelial cells. Proc Natl Acad Sci USA 1998; 95:11709-14.
Olsson AK, DimbergA, Kreuger J, Claesson-Welsh L. VEGF receptor signaling in
control of vascular function. Nat Rev Mol Cell Biol 2006; 7:359-71.
Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term
survival after hepatic resection for metastatic colorectal cancer: a multifactorial
model of 929 patients. Ann Surg 2008; 247:125-35.
Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE. Epidermal growth factor
receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage
II colon cancer: a tissue microarray study. Clin Cancer Res 2004; 10:3069-75.
Ryan HE, Lo J, Johnson RS. HIF-1 is required for solid tumor formation and
embryonic vascularization. EMBO J 1998; 17:3005-15.
Sawano A, Takahashi T, Yamaguchi S, Shibuya M. Sawano A, Takahashi T. The
phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a
major binding site for PLC. Biochem Biophys Res Commun 1997; 238:487-91.
Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S. Epidermal
growth factor receptor (EGFR) status in primary colorectal tumors does not correlate
with EGFR expression in related metastatic sites: implications for treatment with
EGFR targeted monoclonal antibodies. J Clin Oncol 2004; 22:4772-8.
Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after
hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.
Scheele J, Stangl R, Altendorf-Hofmann A. Resection of colorectal liver metastases.
World J Surg 1995; 19:59-71.